CHE
$454.44
Chemed
($11.10)
(2.38%)
CHE
Earnings Whisper ®
N/A
4th Quarter December 2025
Consensus:  $6.40
Revenue:  N/A
Tuesday
Jan 27
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CHE reports earnings?
Beat
Meet
Miss

Where is CHE's stock price going from here?
Up
Flat
Down
Stock chart of CHE
Analysts
Summary of analysts' recommendations for CHE
Score
Grade
Pivots
Resistance
$532.42
$504.63
$485.09

$457.30

Support
$437.76
$409.97
$390.43
Tweet
Growth
Description
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Peers
Humana